Platelet Activation and Glucose Transporters in Preeclampsia
Summary
We are looking at activation of platelets (clotting factors in the blood) in women with pre-eclampsia or at risk of pre-eclampsia and comparing them to healthy pregnant controls.
We are recruiting pregnant women who either have a low or high risk pre-eclampsia screen in the first trimester (between 11-14 weeks gestation), have a prior history of pre-eclampsia, have gestational hypertension or have been diagnosed with pre-eclampsia in this pregnancy
Eligibility
Eligible ages: 18 to 45
Accepts healthy participants: Yes
Inclusion criteria:
1) 18 years of age or older and currently pregnant
2) Speak and understand English
3) Able to attend additional assessment appointments and participate in blood draws
Exclusion criteria:
1) Diagnosed with an autoimmune disease, renal disease, cardiovascular disease, low platelets or clotting disorder
2) Receiving injectable blood thinners- either for a past clot or a current clot
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
Nancy Soliman Nancy.Soliman@ahs.ca
Principal investigator:
Lorraine Chow
Clinical trial:
No
REB-ID:
REB22-0785